I talked to her as well. Had some time on my hands today. I think their RUO 'launch' is allowing interested investigators to 'try out' the blood test up to a max of 10 samples. I didn't get a lot of detail on that one but she said something like that. Seems odd. Seems like their company is very small and they rushed to do these studies and get something to 'sample', not launch in RUO. I couldn't imagine a large Pharma or Diagnostic hooking up with them. She kept saying there is room for many biomarkers in this space. She wanted to get the CFO and/or CEO to call me if I wanted to invest. Shot that one down politely. They will be at JP Morgan but definitely not presenting. The impression I got was they need funding very badly. They may be 'launching' in RUO with a sample but I don't think it will really be ready for RUO or CLIA for some time.